MARY PAUL to Prospective Studies
This is a "connection" page, showing publications MARY PAUL has written about Prospective Studies.
Connection Strength
0.110
-
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. J Acquir Immune Defic Syndr. 2022 07 01; 90(3):343-350.
Score: 0.022
-
Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):303-309.
Score: 0.021
-
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021 07 01; 35(8):1191-1199.
Score: 0.020
-
Trends in post-partum viral load among women living with perinatal HIV infection in the USA: a prospective cohort study. Lancet HIV. 2020 03; 7(3):e184-e192.
Score: 0.018
-
Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV. Clin Infect Dis. 2016 07 01; 63(1):133-137.
Score: 0.014
-
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children. Clin Infect Dis. 2009 Feb 01; 48(3):338-46.
Score: 0.009
-
Changing trends in clinical AIDS presentations and survival among HIV-1-infected women. J Womens Health (Larchmt). 2004 Jul-Aug; 13(6):719-30.
Score: 0.006